Most of the central nervous system (CNS) disorders have always been perceived as challenging pathologies, which is generally attributed to the presence of the formidable blood-brain barrier (BBB). Multiple Sclerosis (MS) is one of such CNS disorders that affect young adults. MS is an autoimmune, neurodegenerative, non-traumatic disease that leads to disability and is characterized by chronic inflammation, local demyelination, scars involving a dense fibrous network of neuroglial cells, destruction of axons, and significant immune cell infiltration. Though various neuroprotective drugs are available for its treatment, its complete reversal is generally not possible due to the failure of conventional approaches to deliver the drug precisely. Thus, there is a need to develop novel strategies for drug delivery to treat MS effectively. Delivery of drug to brain via nose is a non-invasive way that delivers the drug through trigeminal and olfactory pathways, thereby circumventing the blood-brain barrier. Moreover, drug degradation as well as the loss associated with systemic clearance is also reduced which leads to enhanced drug concentration in the brain and results in dose reduction. However, nasal drug delivery systems are associated with certain limitations like variable drug permeation through the nasal mucosa and mucociliary clearance. Various drug delivery approaches (nano-drug carriers, mucoadhesive devices, prodrugs, etc.) have been explored to overcome these issues and target the brain through intranasal administration. Although there is considerable progress in nasal delivery of nanomedicines for treating CNS-related disorders, very little is known regarding their potential in MS. The current manuscript highlights the pathophysiology of MS, mechanism involved in drug delivery from nose to brain, application of nanomedicines in the diagnosis and treatment of MS, the animal models for the evaluation of in vivo potential, and the research done till date.

1.
R. M.
Ransohoff
,
D. A.
Hafler
and
C. F.
Lucchinetti
,
Nature Reviews Neurology
11
(
3
),
134
142
(
2015
).
2.
G.
Ghalamfarsa
,
M.
Hojjat-Farsangi
,
M.
Mohammadnia-Afrouzi
,
E.
Anvari
,
S.
Farhadi
,
M.
Yousefi
and
F.
Jadidi-Niaragh
,
J Immunotoxicol
13
(
5
),
603
619
(
2016
).
3.
A.
Mishra
,
R.
Bandopadhyay
,
P. K.
Singh
,
P. S.
Mishra
,
N.
Sharma
and
N.
Khurana
,
Metabolic Brain Disease
36
(
7
),
1591
1626
(
2021
).
4.
G. G.
Ortiz
,
F. P.
Pacheco-Moises
,
M. A.
Macias-Islas
,
L. J.
Flores-Alvarado
,
M. A.
Mireles-Ramirez
,
E. D.
Gonzalez-Renovato
,
V. E.
Hernandez-Navarro
,
A. L.
Sanchez-Lopez
and
M. A.
Alatorre-Jimenez
,
Arch Med Res
45
(
8
),
687
697
(
2014
).
5.
H.
Lassmann
,
W.
Bruck
,
C.
Lucchinetti
and
M.
Rodriguez
,
Mult Scler
3
(
2
),
133
136
(
1997
).
6.
P.
Kokhaei
,
F.
Jadidi-Niaragh
,
A. Sotoodeh
Jahromi
,
A.
Osterborg
,
H.
Mellstedt
and
M.
Hojjat-Farsangi
,
J Drug Target
24
(
5
),
373
385
(
2016
).
7.
C.
Spuch
and
C.
Navarro
,
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
4
(
3
),
190
205
(
2010
).
8.
G.
Loch-Neckel
and
J.
Koepp
,
Rev Neurol
51
(
3
),
165
174
(
2010
).
9.
R. M.
Ransohoff
and
B.
Engelhardt
,
Nat Rev Immunol
12
(
9
),
623
635
(
2012
).
10.
N. N.
Salama
,
N. D.
Eddington
and
A.
Fasano
,
Adv Drug Deliv Rev
58
(
1
),
15
28
(
2006
).
11.
S.
Cramer
,
H.
Simonsen
,
J.
Frederiksen
,
E.
Rostrup
and
H. B. W.
Larsson
,
NeuroImage: Clinical
4
,
182
189
(
2014
).
12.
A.
Nair
,
T. J.
Frederick
and
S. D.
Miller
,
Cellular and molecular life sciences
65
(
17
),
2702
2720
(
2008
).
13.
C.
Cassan
and
R. S.
Liblau
,
J Neurochem
100
(
4
),
883
892
(
2007
).
14.
M.
Chountoulesi
and
C.
Demetzos
,
Brain Sci
10
(
6
),
338
(
2020
).
15.
S.
Duchi
,
H.
Ovadia
and
E.
Touitou
,
Journal of neuroimmunology
258
(
1-2
),
32
40
(
2013
).
16.
E. E.
Tillery
,
J. N.
Clements
and
Z.
Howard
,
Ment Health Clin
7
(
5
),
213
220
(
2017
).
17.
M.
Gironi
,
C.
Arnò
,
G.
Comi
,
G.
Penton-Rol
and
R.
Furlan
, in Immune Rebalancing (
Elsevier
,
2016
), pp.
63
84
.
18.
F. K.
Nally
,
C.
De Santi
and
C. E.
McCoy
,
Cells
8
(
6
),
543
(
2019
).
19.
20.
M. C.
Bonferoni
,
S.
Rossi
,
G.
Sandri
,
F.
Ferrari
,
E.
Gavini
,
G.
Rassu
and
P.
Giunchedi
,
Pharmaceutics
11
(
2
),
84
(
2019
).
21.
S. V.
Dhuria
,
L. R.
Hanson
and
W. H.
Frey
, 2nd,
J Pharm Sci
99
(
4
),
1654
1673
(
2010
).
22.
A.
Thakur
,
P. K.
Singh
,
S. S.
Biswal
,
N.
Kumar
,
C. B.
Jha
,
G.
Singh
,
C.
Kaur
,
S.
Wadhwa
and
R.
Kumar
,
Journal of Reports in Pharmaceutical Sciences
9
(
1
),
168
(
2020
).
23.
V.
Bourganis
,
O.
Kammona
,
A.
Alexopoulos
and
C.
Kiparissides
,
Eur J Pharm Biopharm
128
,
337
362
(
2018
).
24.
R. G.
Thorne
,
G. J.
Pronk
,
V.
Padmanabhan
and
W. H.
Frey
, 2nd,
Neuroscience
127
(
2
),
481
496
(
2004
).
25.
A.
Mistry
,
S.
Stolnik
and
L.
Illum
,
Int J Pharm
379
(
1
),
146
157
(
2009
).
26.
A.
Dalpiaz
,
M.
Fogagnolo
,
L.
Ferraro
,
A.
Capuzzo
,
B.
Pavan
,
G.
Rassu
,
A.
Salis
,
P.
Giunchedi
and
E.
Gavini
,
Antiviral Res
123
,
146
157
(
2015
).
27.
A.
Weerasuriya
and
A. P.
Mizisin
,
Methods Mol Biol
686
,
149
173
(
2011
).
28.
D.
Sharma
,
R. K.
Sharma
,
N.
Sharma
,
R.
Gabrani
,
S. K.
Sharma
,
J.
Ali
and
S.
Dang
,
AAPS PharmSciTech
16
(
5
),
1108
1121
(
2015
).
29.
A.
Yalcin
,
E.
Soddu
,
E. T.
Bayrakdar
,
Y.
Uyanikgil
,
L.
Kanit
,
G.
Armagan
,
G.
Rassu
,
E.
Gavini
and
P.
Giunchedi
,
Journal of pharmaceutical sciences
105
(
8
),
2372
2380
(
2016
).
30.
M. I.
Ugwoke
,
N.
Verbeke
and
R.
Kinget
,
J Pharm Pharmacol
53
(
1
),
3
21
(
2001
).
31.
R.
Kumar
,
M.
Gulati
,
S. K.
Singh
,
D.
Sharma
and
O.
Porwal
,
CNS & Neurological Disorders-Drug Targets
(Formerly Current Drug Targets-CNS & Neurological Disorders)
19
(
9
),
663
675
(
2020
).
32.
G.
Rassu
,
E.
Soddu
,
A. M.
Posadino
,
G.
Pintus
,
B.
Sarmento
,
P.
Giunchedi
and
E.
Gavini
,
Colloids and Surfaces B: Biointerfaces
152
,
296
301
(
2017
).
33.
F.
Sonvico
,
A.
Clementino
,
F.
Buttini
,
G.
Colombo
,
S.
Pescina
,
S. Staniscuaski
Guterres
,
A. Raffin
Pohlmann
and
S.
Nicoli
,
Pharmaceutics
10
34
(
2018
).
34.
T.
Dube
,
S.
Chibh
,
J.
Mishra
and
J. J.
Panda
,
ACS Chemical Neuroscience
8
(
10
),
2105
2117
(
2017
).
35.
X.
Zhuang
,
X.
Xiang
,
W.
Grizzle
,
D.
Sun
,
S.
Zhang
,
R. C.
Axtell
,
S.
Ju
,
J.
Mu
,
L.
Zhang
,
L.
Steinman
,
D.
Miller
and
H. G.
Zhang
,
Mol Ther
19
(
10
),
1769
1779
(
2011
).
36.
R. G.
Pertwee
,
Pharmacol Ther
95
(
2
),
165
174
(
2002
).
37.
R. C.
Kaufman
, (Google Patents,
2018
).
38.
S.
Ojha
,
B.
Kumar
and
H.
Chadha
,
Indian Journal of Pharmaceutical Sciences
81
(
3
),
496
502
(
2019
).
39.
D. G.
Gadhave
and
C. R.
Kokare
,
Drug Dev Ind Pharm
45
(
5
),
839
851
(
2019
).
40.
J.
Matías-Guiu
,
U.
Gomez-Pinedo
,
P.
Montero-Escribano
,
P.
Gomez-Iglesias
,
J.
Porta-Etessam
and
J.
Matias-Guiu
,
Neurología (English Edition)
35
(
3
),
170
175
(
2020
).
41.
S.
Ojha
and
B.
Kumar
,
Journal of Cellular Immunotherapy
4
(
2
),
56
64
(
2018
).
42.
R. S.
Khan
,
K.
Dine
,
B.
Bauman
,
M.
Lorentsen
,
L.
Lin
,
H.
Brown
,
L. R.
Hanson
,
A. L.
Svitak
,
H.
Wessel
,
L.
Brown
and
K. S.
Shindler
,
Sci Rep
7
(
1
),
41768
(
2017
).
43.
D. G.
Georganopoulou
,
L.
Chang
,
J. M.
Nam
,
C. S.
Thaxton
,
E. J.
Mufson
,
W. L.
Klein
and
C. A.
Mirkin
,
Proc Natl Acad Sci U S A
102
(
7
),
2273
2276
(
2005
).
44.
J.-M.
Nam
,
K.-J.
Jang
and
J. T.
Groves
,
Nature Protocols
2
(
6
),
1438
1444
(
2007
).
45.
J. B.
Warntjes
,
O. D.
Leinhard
,
J.
West
and
P.
Lundberg
,
Magn Reson Med
60
(
2
),
320
329
(
2008
).
46.
A. J.
Haes
,
L.
Chang
,
W. L.
Klein
and
R. P.
Van Duyne
,
Journal of the American Chemical Society
127
(
7
),
2264
2271
(
2005
).
47.
N. E.
Kurland
,
Z.
Drira
and
V. K.
Yadavalli
,
Micron
43
(
2-3
),
116
128
(
2012
).
48.
A.
Neely
,
C.
Perry
,
B.
Varisli
,
A. K.
Singh
,
T.
Arbneshi
,
D.
Senapati
,
J. R.
Kalluri
and
P. C.
Ray
,
ACS nano
3
(
9
),
2834
2840
(
2009
).
49.
(
2012
), Vol.
2022
.
50.
U.
Mushtaq
and
S. K.
Singh
,
presented at the 2018 International Conference on Intelligent Circuits and Systems (ICICS
),
2018
(unpublished).
51.
Y.
Heta
,
K.
Kumaki
,
H.
Hifumi
,
D.
Citterio
,
A.
Tanimoto
and
K.
Suzuki
,
Photochemistry and photobiology
88
(
4
),
876
883
(
2012
).
52.
J. M.
Richards
,
C. A.
Shaw
,
N. N.
Lang
,
M. C.
Williams
,
S. I.
Semple
,
T. J.
MacGillivray
,
C.
Gray
,
J. H.
Crawford
,
S. R.
Alam
and
A. P.
Atkinson
,
Circulation: Cardiovascular Imaging
5
(
4
),
509
517
(
2012
).
53.
S.
Santra
,
S. D.
Jativa
,
C.
Kaittanis
,
G.
Normand
,
J.
Grimm
and
J. M.
Perez
,
ACS nano
6
(
8
),
7281
7294
(
2012
).
54.
A. H.
Jacobs
,
B.
Tavitian
and
I. N.
consortium
,
J Cereb Blood Flow Metab
32
(
7
),
1393
1415
(
2012
).
55.
C.
Procaccini
,
V.
De Rosa
,
V.
Pucino
,
L.
Formisano
and
G.
Matarese
,
Eur J Pharmacol
759
,
182
191
(
2015
).
56.
M.
Kipp
,
S.
Nyamoya
,
T.
Hochstrasser
and
S.
Amor
,
Brain Pathol
27
(
2
),
123
137
(
2017
).
57.
F.
Miyagawa
,
J.
Gutermuth
,
H.
Zhang
and
S. I.
Katz
,
Journal of autoimmunity
35
(
3
),
192
198
(
2010
).
58.
J. L.
Berard
,
K.
Wolak
,
S.
Fournier
and
S.
David
,
Glia
58
(
4
),
434
445
(
2010
).
59.
A. C.
Anderson
,
R.
Chandwaskar
,
D. H.
Lee
,
J. M.
Sullivan
,
A.
Solomon
,
R.
Rodriguez-Manzanet
,
B.
Greve
,
R. A.
Sobel
and
V. K.
Kuchroo
,
J Immunol
188
(
5
),
2084
2092
(
2012
).
60.
I.
Tsunoda
and
R. S.
Fujinami
,
Journal of neuroimmune pharmacology
5
(
3
),
355
369
(
2010
).
61.
W. F.
Blakemore
and
R. J.
Franklin
,
Curr Top Microbiol Immunol
318
,
193
212
(
2008
).
62.
A. J.
Bieber
,
S.
Kerr
and
M.
Rodriguez
,
Ann Neurol
53
(
5
),
680
684
(
2003
).
63.
Y.
Barenholz
,
A. A.
Gabizon
and
Y.
Avnir
, (Google Patents,
2015
).
64.
A.
Gabibov
,
A.
Belogurov
and
N.
Ponomarenko
, (Google Patents,
2016
).
65.
S. J.
Tam
,
T.
Yednock
,
Y.
Liu
,
N.
Schwab
,
H.
Wiendl
and
T.
Schneider-Hohendorf
, (Google Patents,
2017
).
66.
R. L.
Watson
,
A. B.
Wood
and
G. J.
Archambeau
, (Google Patents,
2017
).
67.
T.
DELLOVADE
, (Google Patents,
2018
).
68.
M.
Novas
, (Google Patents,
2018
).
69.
P.
Santamaria
, (Google Patents,
2018
).
70.
N.
Tarcic
,
D.
Bar-Zohar
and
D.
Kofler
, (Google Patents,
2018
).
71.
D.
Weinstein
, (Google Patents,
2018
).
72.
B.
Finck
,
R.
Zivadinov
and
H.
Tang
, (Google Patents,
2019
).
73.
C.
Smith
and
P. S.
Chin
, (Google Patents,
2019
).
74.
E. S.
Smith
and
T. L.
Fisher
, (Google Patents,
2019
).
75.
T.
Terwey
,
R.
Rupp
and
P. M.
Andersen
, (Google Patents,
2019
).
76.
B. T.
Gurfein
, (Google Patents,
2020
).
77.
T. A.
Luger
and
K.
Loser
, (Google Patents,
2020
).
78.
T.
Maes
,
C. M.
CRUSAT
and
D. R.
POZO
, (Google Patents,
2020
).
79.
C.
Smith
and
P. S.
Chin
, (Google Patents,
2021
).
80.
R. R.
Voskuhl
, (Google Patents,
2021
).
This content is only available via PDF.
You do not currently have access to this content.